Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy

Clinical trial NCT06357754 · RECRUITING

Trial details

NCT number: NCT06357754
Sponsor: Bristol-Myers Squibb
Status: RECRUITING
Study type: OBSERVATIONAL

Non-Hodgkin Lymphoma Chronic Lymphocytic Leukaemia Multiple Myeloma

Start date: 2023-10-06
Primary completion: 2038-10-06
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.